Drug Shortage Report for 5% DEXTROSE INJECTION, USP
Report ID | 165965 |
Drug Identification Number | 00060348 |
Brand name | 5% DEXTROSE INJECTION, USP |
Common or Proper name | 5% DEXTROSE INJECTION, USP |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE |
Strength(s) | 5G |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 100mL (JB0082P) |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-08-04 |
Actual start date | 2022-08-04 |
Estimated end date | 2022-08-29 |
Actual end date | 2022-08-29 |
Shortage status | Resolved |
Updated date | 2022-08-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-08-03 | English | Compare |
v2 | 2022-08-03 | French | Compare |
v3 | 2022-08-05 | English | Compare |
v4 | 2022-08-23 | English | Compare |
v5 | 2022-08-23 | French | Compare |
v6 | 2022-08-29 | English | Compare |
v7 | 2022-08-29 | French | Compare |
v8 | 2022-08-30 | English | Compare |
Showing 1 to 8 of 8